Marlan D Walker insider trades
Open-market stock purchases and sales by Marlan D Walker, Chief Executive Officer at TherapeuticsMD, Inc, from SEC Form 4 filings since May 10, 2021.
Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +108%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Nov 3, 2025 | TXMD TherapeuticsMD, Inc | Bought (not open market) | — |
Companies traded
- TXMD TherapeuticsMD, Inc: 3 buys, 6 sales, last Nov 3, 2025